| Familial hypercholesterolaemia: a model of care for Australasia | Atherosclerosis Supplements | 2011 | 153 |
| Cardiometabolic risk factors in people with psychotic disorders: the second Australian national survey of psychosis | Australian and New Zealand Journal of Psychiatry | 2012 | 152 |
| Meta-analysis of genome-wide linkage studies in BMI and obesity | Obesity | 2007 | 122 |
| Association of plasma phospholipid long-chain ω-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study | Circulation | 2012 | 112 |
| Non-adherence to statin therapy: a major challenge for preventive cardiology | Expert Opinion on Pharmacotherapy | 2009 | 93 |
| Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation | Journal of Clinical Lipidology | 2014 | 79 |
| Complete deficiency of the low-density lipoprotein receptor is associated with increased apolipoprotein B-100 production | Arteriosclerosis, Thrombosis, and Vascular Biology | 2005 | 68 |
| Hypoallergenic Der p 1/Der p 2 combination vaccines for immunotherapy of house dust mite allergy | Journal of Allergy and Clinical Immunology | 2012 | 63 |
| Revisiting the metabolic syndrome | Medical Journal of Australia | 2006 | 51 |
| MTP inhibition as a treatment for dyslipidaemias: time to deliver or empty promises? | Expert Opinion on Therapeutic Targets | 2007 | 49 |
| Rationale for a trial of low-dose aspirin for the primary prevention of major adverse cardiovascular events and vascular dementia in the elderly: Aspirin in Reducing Events in the Elderly (ASPREE) | Drugs and Aging | 2003 | 48 |
| Feasibility of conducting a primary prevention trial of low-dose aspirin for major adverse cardiovascular events in older people in Australia: results from the ASPirin in Reducing Events in the Elderly (ASPREE) pilot study | Medical Journal of Australia | 2008 | 47 |
| Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia | Heart Lung and Circulation | 2014 | 44 |
| A systematic review of economic evaluations of the detection and treatment of familial hypercholesterolemia | International Journal of Cardiology | 2013 | 44 |
| The erectile-endothelial dysfunction nexus: new opportunities for cardiovascular risk prevention | Nature Clinical Practice Cardiovascular Medicine | 2007 | 44 |
| Cardiometabolic risk indicators that distinguish adults with psychosis from the general population, by age and gender | PLoS ONE | 2013 | 33 |
| Inadequate fruit and vegetable intake in people with psychosis | Australian and New Zealand Journal of Psychiatry | 2014 | 31 |
| Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: a pilot study | Journal of Clinical Lipidology | 2015 | 30 |
| Predictors of type 2 diabetes in a nationally representative sample of adults with psychosis | World Psychiatry | 2014 | 25 |
| Lipoprotein apheresis and new therapies for severe familial hypercholesterolemia in adults and children | Best Practice and Research in Clinical Endocrinology and Metabolism | 2014 | 24 |
| Screening for familial hypercholesterolaemia | Pathology | 2012 | 23 |
| Spontaneous pneumothorax in diffuse cystic lung diseases | Current Opinion in Pulmonary Medicine | 2017 | 22 |
| Can patients be accurately assessed for familial hypercholesterolaemia in primary care? | Heart Lung and Circulation | 2014 | 22 |
| Severe HDL deficiency due to novel defects in the ABCA1 transporter | Journal of Internal Medicine | 2009 | 22 |
| Detecting familial hypercholesterolaemia in the community: impact of a telephone call from a chemical pathologist to the requesting general practitioner | Atherosclerosis | 2014 | 21 |
